ALEPLASININ - EFFECT, APPLICATION & RISKS - ACTIVE INGREDIENTS

Aleplasinine



Editor'S Choice
Intestinal atony (paralysis)
Intestinal atony (paralysis)
A drug is currently being developed from the active ingredient aleplasinin, which is to be used in the treatment of Alzheimer's disease. The preparation is designed to prevent deposits from forming, which cause brain cells to die, thereby causing the disease